Medical castration in the treatment of widespread cancers of the prostate. The role of buserelin
Medical castration with LHRH agonists is a significant trend in the treatment of locally advanced and metastatic prostate cancer (PC).The article is devoted to the effectiveness of synthetic LHRH agonist buserelin (Buserelin-depo) Portable Chargers in the treatment of patients with hormone dependent PC.Administration Filter Carbon of Buserelin-depo